2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide

C148H195N17O32S9 — CID 161345398

About 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide

2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide (PubChem CID 161345398) has the molecular formula C148H195N17O32S9 and a molecular weight of 3012.88 g/mol. Its IUPAC name is 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide.

Molecular Properties

• Compound Name: 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide
• PubChem CID: 161345398
• Molecular Formula: C148H195N17O32S9
• Molecular Weight: 3012.88 g/mol
• Exact Mass: 3010.16
• IUPAC Name: 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide
• SMILES: CCC(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC(C)O)S(=O)(=O)c1ccco1.CCC(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC1CC1)S(=O)(=O)c1ccco1.Cc1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)O)S(=O)(=O)c2sc(C)nc2C)n1.Cc1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC2CC2)S(=O)(=O)c2ccco2)n1.Cc1nc(C)c(S(=O)(=O)N(CC2CC2)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C[C@H]2C=CCC2)s1.Cc1nc(C)c(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C[C@H]2C=CCC2)C[C@@H](C)O)s1
• InChI: InChI=1S/C26H35N3O4S2.C25H32N4O5S2.C25H35N3O5S2.C25H29N3O5S.C24H32N2O6S.C23H32N2O7S/c1-18-26(34-19(2)27-18)35(32,33)29(16-22-12-13-22)17-24(30)23(14-20-8-4-3-5-9-20)28-25(31)15-21-10-6-7-11-21;1-16-9-8-12-21(26-16)24(32)28-22(13-20-10-6-5-7-11-20)23(31)15-29(14-17(2)30)36(33,34)25-18(3)27-19(4)35-25;1-17(29)15-28(35(32,33)25-18(2)26-19(3)34-25)16-23(30)22(13-20-9-5-4-6-10-20)27-24(31)14-21-11-7-8-12-21;1-18-7-5-10-21(26-18)25(30)27-22(15-19-8-3-2-4-9-19)23(29)17-28(16-20-12-13-20)34(31,32)24-11-6-14-33-24;1-2-20(27)12-13-23(29)25-21(15-18-7-4-3-5-8-18)22(28)17-26(16-19-10-11-19)33(30,31)24-9-6-14-32-24;1-3-19(27)11-12-22(29)24-20(14-18-8-5-4-6-9-18)21(28)16-25(15-17(2)26)33(30,31)23-10-7-13-32-23/h3-6,8-10,21-24,30H,7,11-17H2,1-2H3,(H,28,31);5-12,17,22-23,30-31H,13-15H2,1-4H3,(H,28,32);4-7,9-11,17,21-23,29-30H,8,12-16H2,1-3H3,(H,27,31);2-11,14,20,22-23,29H,12-13,15-17H2,1H3,(H,27,30);3-9,14,19,21-22,28H,2,10-13,15-17H2,1H3,(H,25,29);4-10,13,17,20-21,26,28H,3,11-12,14-16H2,1-2H3,(H,24,29)/t21-,23-,24+;17?,22-,23+;17-,21+,22+,23-;22-,23+;21-,22+;17?,20-,21+/m001000/s1
• InChIKey: VNFLJFLXRCKGAP-DMHKFADPSA-N
• XLogP: 15.23
• TPSA: 718.96 Ų
• H-Bond Donors: 15
• H-Bond Acceptors: 40
• Rotatable Bonds: 74
• Heavy Atoms: 206
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3012.88
LogP ≤ 5	15.23
H-Bond Donors ≤ 5	15
H-Bond Acceptors ≤ 10	40

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide?

The IUPAC name of 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide (CID 161345398) is 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide.

What is the SMILES notation for 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide?

The canonical SMILES for 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide is CCC(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC(C)O)S(=O)(=O)c1ccco1.CCC(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC1CC1)S(=O)(=O)c1ccco1.Cc1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)O)S(=O)(=O)c2sc(C)nc2C)n1.Cc1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC2CC2)S(=O)(=O)c2ccco2)n1.Cc1nc(C)c(S(=O)(=O)N(CC2CC2)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C[C@H]2C=CCC2)s1.Cc1nc(C)c(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C[C@H]2C=CCC2)C[C@@H](C)O)s1.

What is the InChIKey of 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide?

The InChIKey is VNFLJFLXRCKGAP-DMHKFADPSA-N. The full InChI is InChI=1S/C26H35N3O4S2.C25H32N4O5S2.C25H35N3O5S2.C25H29N3O5S.C24H32N2O6S.C23H32N2O7S/c1-18-26(34-19(2)27-18)35(32,33)29(16-22-12-13-22)17-24(30)23(14-20-8-4-3-5-9-20)28-25(31)15-21-10-6-7-11-21;1-16-9-8-12-21(26-16)24(32)28-22(13-20-10-6-5-7-11-20)23(31)15-29(14-17(2)30)36(33,34)25-18(3)27-19(4)35-25;1-17(29)15-28(35(32,33)25-18(2)26-19(3)34-25)16-23(30)22(13-20-9-5-4-6-10-20)27-24(31)14-21-11-7-8-12-21;1-18-7-5-10-21(26-18)25(30)27-22(15-19-8-3-2-4-9-19)23(29)17-28(16-20-12-13-20)34(31,32)24-11-6-14-33-24;1-2-20(27)12-13-23(29)25-21(15-18-7-4-3-5-8-18)22(28)17-26(16-19-10-11-19)33(30,31)24-9-6-14-32-24;1-3-19(27)11-12-22(29)24-20(14-18-8-5-4-6-9-18)21(28)16-25(15-17(2)26)33(30,31)23-10-7-13-32-23/h3-6,8-10,21-24,30H,7,11-17H2,1-2H3,(H,28,31);5-12,17,22-23,30-31H,13-15H2,1-4H3,(H,28,32);4-7,9-11,17,21-23,29-30H,8,12-16H2,1-3H3,(H,27,31);2-11,14,20,22-23,29H,12-13,15-17H2,1H3,(H,27,30);3-9,14,19,21-22,28H,2,10-13,15-17H2,1H3,(H,25,29);4-10,13,17,20-21,26,28H,3,11-12,14-16H2,1-2H3,(H,24,29)/t21-,23-,24+;17?,22-,23+;17-,21+,22+,23-;22-,23+;21-,22+;17?,20-,21+/m001000/s1.

What are the key properties of 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide?

2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide has a molecular weight of 3012.88 g/mol, XLogP of 15.23, 74 rotatable bonds, 15 hydrogen bond donors, and 40 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[cyclopropylmethyl-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;2-[(1S)-cyclopent-2-en-1-yl]-N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-[(2R)-2-hydroxypropyl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[cyclopropylmethyl(furan-2-ylsulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide;N-[(2S,3R)-4-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl-(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-6-methylpyridine-2-carboxamide;N-[(2S,3R)-4-[furan-2-ylsulfonyl(2-hydroxypropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-4-oxohexanamide is sourced from PubChem (CID 161345398), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).